Education
About Us
Working with TipRanks
Follow Us
Lynne Parshall Insider Profile
4 Followers
Lynne Parshall, Director at Ionis Pharmaceuticals, holds 91.34K shares in Ionis Pharmaceuticals (Ticker: IONS), holds ― shares in Akcea Therapeutics (Ticker: AKCA), holds ― shares in Foghorn Therapeutics (Ticker: FHTX).
Profitable Transactions
10 out of 10 Profitable Transactions
Average Return
+31.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Lynne Parshall holds in companies
Most Profitable Insider Trade
The most profitable trade made by Lynne Parshall
Lynne Parshall's Trading History
Ionis Pharmaceuticals
Jul 17, 2025
Director
Uninformative Buy
171.32K
$3.83M
Akcea Therapeutics
―
―
―
―
Foghorn Therapeutics
―
Director
―
―
Cytokinetics
May 15, 2025
Director
Uninformative Buy
―
$1.05M
Regulus
Oct 11, 2012
―
Uninformative Buy
―
$57.52M
List of latest transactions for each holding click on a transaction to see Lynne Parshall's performance on stock
You May Also Like
Lynne Parshall insider profile FAQ
What is the percentage of profitable transactions made by Lynne Parshall?
The percentage of profitable transactions made by Lynne Parshall is 100%.
What is the average return per transaction made by Lynne Parshall?
The average return per transaction made by Lynne Parshall is 31.70%.
What stocks does Lynne Parshall hold?
Lynne Parshall holds: IONS, AKCA, FHTX, CYTK, RGLS stocks.
What was Lynne Parshall’s latest transaction?
Lynne Parshall latest transaction was an Uninformative Buy of $171.32K.
What was Lynne Parshall's most profitable transaction?
Lynne Parshall’s most profitable transaction was an Informative Sell of CYTK stock on July 1, 2024. The return on the trade was 38.50%.
What is Lynne Parshall's role in Ionis Pharmaceuticals?
Lynne Parshall's role in Ionis Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.